Objectives: Metabolic alterations after burn injury have been well described in children; however, in adult patients, glucose metabolism and insulin sensitivity are essentially unknown. We sought to characterize metabolic alterations and insulin resistance after burn injury and determine their magnitude and persistence at discharge. Design: Prospective, cohort study. Setting: Tertiary burn centre. Patients: Nondiabetic adults with an acute burn involving greater than or equal to 20% total body surface area. Interventions: An oral glucose tolerance test was administered at discharge. Measurements and Main Results: Glucose, insulin, and C-peptide levels were measured to derive surrogate measures of insulin resistance and β-cell function, including quantitative insulin sensitivity check index, homeostasis model assessment of β-cell function, homeostasis model assessment of insulin sensitivity, homeostasis model assessment of insulin resistance, and the composite whole-body insulin sensitivity index. Patients were grouped according to the degree of glucose tolerance: normal glucose tolerance, impaired fasting glucose/impaired glucose tolerance, or diabetes. Forty-five adults, 44 ± 15 years old and with 38% ± 14% total body surface area burned, underwent an oral glucose tolerance test at discharge. Median quantitative insulin sensitivity check index (0.348 [0.332-0.375]) and median homeostasis model assessment of insulin resistance (1.13 [0.69-1.45]) were abnormal, indicating insulin resistance and impaired insulin production at discharge. Two-thirds of patients (n = 28) met criteria for impaired fasting glucose/impaired glucose tolerance or diabetes. Conclusions: We have demonstrated that burn-injured adults remain hyperglycemic, are insulin resistant, and express defects in insulin secretion at discharge. Patients with lower burn severity (total body surface area, 20-30%) express similar metabolic alterations as patients with larger burns (total body surface area, ≥ 30%). Glucose tolerance testing at discharge offers an opportunity for early identification of burn patients who may be at high risk of prediabetes and diabetes. Our findings demonstrated that two-thirds of burn patients had some degree of glucose intolerance. With this in mind, surveillance of glucose intolerance post discharge should be considered. As hyperglycemia and insulin resistance are associated with poor outcomes, studies should focus on how long these profound alterations persist. (Crit Care Med 2016; 44:1059-1066 A hallmark of severe burns is hypermetabolism associated with hyperglycemia and insulin resistance (1-3). In these patients, hyperglycemia occurs because of increased glucose output in tandem with decreased glucose uptake. Ultimately, this leads to a hyperglycemic, hyperinsulinemic response. Hyperglycemia has been associated with impaired wound healing and increased infections, organ dysfunction, and mortality (2, 4, 5) . Tight glycemic control aims to avoid these hyperglycemic peaks and associated complications
although it must be balanced against the risks of hypoglycemia. Hypoglycemia occurs in 15-20% of burn patients and is associated with an up to nine-fold increase in mortality (6) . Thus, tight glucose control in burn patients is a balancing act; both hypo-and hyperglycemia can lead to poor outcomes.
To date, some postburn metabolic alterations have been delineated although the majority of studies have been conducted in children (5, 7, 8) . There is strong evidence that the postburn hyperglycemic, hyperinsulinemic response persists following the acute phase of injury. Studies in pediatric burn patients demonstrate elevated levels of fasting glucose for up to 6 months and insulin resistance for up to 3 years post injury (7) . Despite the well-documented metabolic alterations in the pediatric population (5, 7, 8) , no studies have examined glucose regulation and insulin resistance in adults after burn injury using the oral glucose tolerance test (OGTT). We aimed to determine the metabolic and physiologic alterations in severely burned adults and to assess insulin resistance both during acute hospitalization and at the time of discharge.
The factors that contribute to insulin resistance in adult burn patients are poorly defined; this might occur through insulin resistance, impaired insulin secretion, or loss of β-cell function. Insulin resistance is defined as a reduced response to insulin (9) , resulting in reduced glucose uptake in the presence of insulin. Prolonged hyperglycemia can induce β-cell dysfunction by exhausting β-cells. The insulin clamp technique is considered the gold standard for determining insulin resistance, but it is limited by its clinical impracticality. Rather, the 2-hour OGTT is used to diagnose glucose intolerance by simulating the postprandial state after ingestion of 75 g of glucose. OGTT-derived indices are noninvasive alternatives to the insulin clamp that are used to estimate surrogate markers of peripheral and hepatic insulin resistance and β-cell function (9) . The final aim of our study was to describe metabolic and physiologic alterations after burn and to compare these responses in clinically relevant subgroups.
MATERIALS AND METHODS

Study Design and Participants
We conducted a prospective cohort study of adults (≥ 18 yr old) with a severe burn injury, defined as greater than or equal to 20% total body surface area (TBSA), admitted to our provincial burn center between June 1, 2011, and June 1, 2015. Patients were excluded if they had a history of diabetes, abnormal glycosylated hemoglobin (Hb A1C) levels at admission, cardiovascular disease, or liver or renal failure. The Canadian Diabetes Association guidelines for Hb A1C levels are diagnostic criteria of 0.060-0.064 for prediabetes and greater than or equal to 0.065 for diabetes (10) . The research ethics board at our institution approved the study protocol, and informed consent was obtained from all patients.
The following patient demographics and injury characteristics were recorded: age at injury, sex, weight, height, percent TBSA burned, the presence of inhalation injury, length of stay (LOS) in hospital, and days to OGTT from injury. Body mass index was calculated as weight (kg)/height 2 (m 2 ). All patients received care in accordance with evidence-based protocols established at our burn centre. This includes a glucose control protocol, targeting a blood glucose range between 90 and 144 mg/dL (5-8 mmol/L) (6) . None of the patients in our study received any anabolic agents, and all inpatient glucose levels and insulin administration were recorded. The Canadian Diabetes Association criteria were used to classify glucose tolerance as 1) normal glucose tolerance (NGT), defined as fasting plasma glucose less than 110 mg/dL (< 6.1 mmol/L) and 2-hour plasma glucose less than 140 mg/dL (< 7.8 mmol/L); 2) impaired fasting glucose (IFG), defined as fasting plasma glucose 110-125 mg/dL (6.1-6.9 mmol/L) and 2-hour plasma glucose less than 140 mg/dL (< 7.8 mmol/L); 3) impaired glucose tolerance (IGT), defined as fasting plasma glucose less than 110 mg/dL (< 6.1 mmol/L) and 2-hour plasma glucose 140-200 mg/dL (7.8-11 .0 mmol/L); or 4) diabetes, defined as fasting glucose greater than or equal to 125 mg/dL (≥ 7.0 mmol/L) or 2-hour glucose 200 mg/dL (≥ 11.1 mmol/L) (10) . For the purposes of this study, IFG/IGT is defined as meeting one or both of the aforementioned criteria for IFG or IGT.
OGTT
Subjects meeting inclusion criteria were administered an OGTT at discharge, and wounds were 95% healed. Patients were not on insulin or β-blockers at the time of OGTT. Patients were fasted overnight, and blood samples were collected at 0, 30, 90, and 120 minutes after ingestion of a standard glucose load (75 g). Plasma glucose concentrations were determined using a hexokinase assay, and serum insulin and C-peptide concentrations were determined by common enzyme-linked immunosorbent assay techniques. Total glucose, insulin, and C-peptide secretion were estimated from the area under the curve (AUC) from 0 to 120 minutes using the trapezoidal rule.
Surrogate Measures of Insulin Resistance and β-Cell Function
The following insulin sensitivity indices were calculated: (15) . Estimates of β-cell function, insulin sensitivity, and insulin resistance were derived from simultaneously measured fasting plasma glucose, fasting specific insulin, and C-peptide values (15) . C-peptide and fasting specific insulin were used to determine β-cell function and insulin sensitivity respectively, as reported by Wallace et al (16) .
Statistical Analysis
The data are reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology statement (17) . Data are expressed as mean ± sd, median (interquartile range [IQR]), or n (%) as appropriate. To identify differences in OGTT profiles and insulin indices, we compared patients based on the degree of glucose tolerance, injury severity (TBSA < 30% vs TBSA ≥ 30%), the presence of inhalation injury, sex, and complications (bacteremia, sepsis, and pneumonia). Groups were compared using Student t test, one-way analysis of variance, Kruskal-Wallis, Mann-Whitney U, Fisher exact, and chi-square tests as appropriate. All tests were two tailed and calculated using SPSS version 20.0 software (IBM SPSS Statistics for Macintosh; Armonk, NY) with a p value of less than 0.05 considered statistically significant.
RESULTS
Patients
Fifty-four patients were assessed for eligibility at our burn center during the study period; of those, 45 (83%) met inclusion criteria (Supplemental Fig. 1 Fig. 2A , Supplemental Digital Content 2, http://links.lww.com/CCM/B756).
OGTT and Surrogate Measures of Insulin Resistance and β-Cell Function
The OGTT profile (Fig. 1) demonstrated that severely burned adults had a hyperglycemic response ( Fig. 1A) and elevated fasting insulin levels (Fig. 1B) . Surrogate measures of insulin resistance and sensitivity were also abnormal, including QUICKI and HOMA2 (Table 1) . Overall, two-thirds (n = 28) of burn patients had some degree of impaired glucose metabolism or diabetes (Fig. 2) . Seventeen patients (38%) were classified as NGT, 20 (44%) as IFG/IGT, and eight (18%) as diabetic. Patient demographics and injury characteristics compared by glucose tolerance classification are summarized in Table 1 . There was a significant difference in age among the three groups (p = 0.017); patients with NGT were the youngest, whereas IFG/IGT were the oldest ( Table 1) .
The OGTT profile (Fig. 3) of adult burn patients, based on the degree of glucose tolerance, demonstrated significant differences in serum glucose at 0, 90, and 120 minutes among the three groups (p = 0.001, p < 0.0001, and p < 0.0001, respectively; Fig. 3A) . As expected, patients classified as diabetic had the highest glucose levels at all time points and those with NGT had the lowest glucose levels at all time points (Fig. 3A) . Elevated fasting insulin levels were observed among all patients, with a significant difference among the three groups at the 120-minute time point (p = 0.0009; Fig. 3B ). Patients meeting criteria for diabetes had a delayed peak in insulin levels after ingestion of the glucose load (Fig. 3B) . In contrast, peak insulin levels for NGT patients occurred at the 30-minute time point. IFG/IGT patients had elevated insulin levels throughout the 120-minute time point (Fig. 3B ). C-peptide levels followed a similar pattern to insulin levels, and there was a significant difference at 120 minutes (p = 0.002; Fig. 3C ). The AUC glucose was significantly different across the three groups (p < 0.0001; Fig. 3D ). Patients classified as diabetics had the largest AUC for glucose ( Fig. 3D) , insulin (Fig. 3E) , and C-peptide ( Fig. 3F) , followed by IFG/IGT and NGT.
There was no significant difference among patients classified with NGT, IFG/IGT, or diabetes for QUICKI, IGI, or HOMA2 estimates of insulin resistance and β-cell function ( Table 1 ). In subjects with NGT, QUICKI, IGI, and HOMA2 estimates were normal. Subjects with IFG/IGT had abnormal QUICKI, IGI, and decreased HOMA2 estimates of insulin sensitivity and β-cell function. The diabetic group had the largest deviation from normal values for all indices (Table 1) . There was a significant difference among the three groups in the ISI (composite); those with diabetes had diminished values, suggesting whole-body insulin resistance (p = 0.001; Table 1 ).
To determine how OGTT profiles vary with injury severity, inhalation injury, gender, and complications, we performed several subgroup analyses. No significant differences in OGTT values or insulin indices were identified based on burn size, inhalation injury, or gender ( Fig. 4; Supplemental Fig. 3 
DISCUSSION
This study demonstrated that burned adults have abnormal glucose metabolism, with degrees of impaired insulin secretion and insulin resistance. Hb A1C values were within the normal range at admission, and average glucose levels throughout the study were within the ideal glucose target range. This suggests that patients did not have elevated glucose levels before injury and that glucose was well controlled during their acute hospitalization. However, at discharge, two-thirds of burn patients have abnormal glucose regulation and are classified with IFG/IGT or diabetes. IFG and IGT are intermediate states that may ultimately lead to diabetes. Although not equivalent metabolically, individuals can be classified as having both IFG and IGT. IFG refers to fasting glucose levels that are higher than normal because of abnormalities in basal insulin secretion or hepatic glucose output. Conversely, in IGT, postprandial plasma glucose levels are higher than normal. Typically, this is because of a defect in insulin production by the β cells or a defect in insulin action (18) . Previous studies in the pediatric burn population (7, 8) observed higher fasting insulin levels than in this study. This suggests that insulin production does not mediate the observed insulin resistance in children. Rather, hyperinsulinemia occurs as a compensatory response to insulin resistance; increasing insulin levels ultimately result in reduced sensitivity to circulating insulin (18) . In contrast, we found that insulin resistance in adults is mediated by β-cell dysfunction and decreased insulin sensitivity. Thus, children experience hyperglycemia associated with hyperinsulinemia, whereas adults experience impaired insulin secretion in addition to hyperglycemia. The hyperinsulinemia in adults is less severe, whereas insulin resistance is a more prominent feature.
Insulin indices demonstrate that burn-injured adults have defective insulin secretion although this was less profound than that observed in severe diabetics. Using C-peptide concentration as a surrogate for β-cell function, we estimate that B-cell function in this cohort was 91% of normal. Similar results were seen when using the IGI as a surrogate for insulin secretion. Taken together, these results suggest that burned adults have impaired early-phase insulin secretion, perhaps a consequence of the hypermetabolic response of the pancreas after β-cell exhaustion. This is consistent with abnormal 2-hour glucose levels. This is a key finding as defects in insulin secretion in IFG and IGT individuals can lead to overt diabetes. Previous work has suggested that insulin resistance may develop as a consequence of decreased muscle mass after burn injury that ultimately leads to decreased glucose uptake by skeletal muscle (3) .
Previous work in our laboratory has characterized the molecular and physiologic mechanisms that might be underlying these metabolic derangements. After burn injury, hyperglycemia and insulin resistance are associated with endoplasmic reticulum (ER) stress in muscle, skin, and fat that persists for up to 250 days after injury (19) . ER stress is associated with 1) conformational changes that prevent insulin receptor signaling and 2) mitochondrial dysfunction and damage (19) (20) (21) (22) (23) . These changes contribute to impairments in insulin-stimulated glucose uptake and fat metabolism, leading to increased concentrations of glucose, fatty acids, and cholesterol (19) . Although both adult and pediatric burn populations demonstrate altered glucose regulation, this study suggests that adults are more likely to develop insulin resistance in response to the metabolic sequelae of burn injury than children. The underlying mechanism of how acquired insulin resistance is associated with subsequent development of diabetes is yet to be elucidated and may represent a significant source of long-term morbidity following major burn injury.
Defects in the insulin-signaling cascade after burn injury are similar to those observed in patients with type II diabetes (3, 23) . This suggests that burn patients quickly move through the compensatory hyperinsulinemia state to the second stage characterized by increased glucose levels and impaired early insulin release (24, 25) . Efforts to prevent or attenuate this progression may be dependent on the underlying pathophysiology. As such, further characterization of the pathophysiologic mechanisms underlying this impaired glucose metabolism is required. With age being a known risk factor for development of diabetes, we expected diabetic patients to be oldest. Interestingly, despite the observed difference among groups in terms of age, IFG/IGT were the oldest. No association between gender, inhalation injury, or burn size and subsequent glucose classification was identified. This is in contrast to a previous study in children that demonstrated an association between increasing burn size and increased hypermetabolism (26) . Our study might be underpowered to detect an effect of burn size, as a very small proportion of patients (n = 3) had a burn injury larger than 60% TBSA. Although a burn severity was not associated with differences in OGTT profiles and insulin indices, a difference may be revealed by future studies with a greater distribution of burn size. However, our results are clinically significant as they suggest that all patients with greater than or equal to 20% TBSA are at risk for the sequelae of glucose intolerance and insulin resistance.
Several limitations of the OGTT and OGTT-derived indices merit discussion. Biologic differences in fasting insulin values may result in more accurate fasting insulin values in patients who have NGT in comparison with patients who have diabetes (27) . Fortunately, several indices are available for use in determining insulin resistance. We employed several indices in order to overcome the limitations and potential biases associated with using a single measure of insulin resistance. Another limitation is that estimates of "normal" can vary depending on conversion factors and the assay used (28) . To decrease assay bias, the same assay sources were used throughout the study. Caution is required when interpreting insulin indices as normal values can vary across different study populations. However, to the best of our knowledge, there are no established normal values for burninjured patients at the time of discharge. Our results are consistent with previously published studies in the pediatric burn population that have shown a hyperglycemic response and insulin resistance, providing external validity to our study (5, 7, 8) . A further limitation is the lack of a control group; OGTTs are not routinely performed unless there is a clinical indication. Even in high-risk populations, not all institutions measure insulin or C-peptide, and laboratories may vary by measurement technique.
In summary, abnormal glucose metabolism and insulin resistance were observed in this cohort of 45 burn-injured patients at the time of discharge. In some patients, these metabolic alterations result in glucose levels associated with frank diabetes. This is a consequence of two pathophysiologic events: 1) impaired insulin secretion and 2) concomitant peripheral insulin resistance. Monitoring burn-injured adults for metabolic alterations might guide therapeutic interventions, such as glucose control post discharge. The trajectory of these derangements in glucose metabolism merits elucidation as it remains unknown whether these changes are transient responses to injury or permanent alterations. It is also unknown whether patients with burns less than 20% TBSA manifest a similar response and if those identified with intermediate states of IFG and IGT or with diabetes have poorer outcomes. Future work should determine the long-term impact of impaired glucose metabolism on patient outcomes, specifically whether these patients are at increased risk of developing diabetes compared with their noninjured counterparts.
